Does Boji Pharmaceutical have relevant favorable policy incentives under the current mechanism?

Yes.

1. Support the research and development of innovative drugs. Chemical drugs, biological products, and traditional Chinese medicines will be supported at 40% of the clinical research and development costs of a single variety. The maximum support for Class I new drugs is 30 million yuan, and the maximum support for Class II new drugs is 15 million yuan.

2. Support the research and development of innovative medical (002173) devices. Support of up to 3 million yuan will be provided to Class III medical devices that initiate clinical trials.

3. Support clinical trials. For registered drug clinical trial institutions in this city that carry out clinical trial research on innovative drugs and innovative medical devices for enterprises in this city and promote the accelerated transformation of scientific research results, the clinical trial institution will be supported at 10% of the clinical trial cost of a single product, with a maximum support of 2 million Yuan.